Overview of the safety of felodipine based on clinical trials in patients with hypertension

American Journal of Cardiology

Volumn 79, Issue 7, 1997, Pages 996-999

  Welin, Lennart ^a   Elvelin, Lars ^a   Niklasson, Anne ^a   Olsson, Gunnar ^a   Elmfeldt, Dag ^a  

^a ASTRAZENECA R AND D   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ANTAGONIST; DIHYDROPYRIDINE DERIVATIVE; FELODIPINE;

CLINICAL TRIAL; DRUG SAFETY; DRUG SCREENING; HEART INFARCTION; HUMAN; HYPERTENSION; INCIDENCE; MORTALITY; PRIORITY JOURNAL; REVIEW; STROKE;

EID: 0030950857     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(97)00034-9     Document Type: Article

References (15)

1. Psaty BM, Heckberg SR, Koepsell TD, Siscovick DS, Raghunathan TE, Weiss NS, Rosendaal FR, Lemaitre RN, Smith NL, Wahl PW, Wagner EH, Furberg CD. The risk of myocardial infarction associated with antihypertensive drug therapies. JAMA. 274:1995;620-625.
2. Furberg CD, Psaty BM, Meyer JV. Nifedipine: dose-related increase in mortality in patients with coronary heart disease. Circulation. 92:1995;1326-1331.
3. Epstein M. Calcium antagonists: still appropriate as first line antihypertensive agents. Am J Hypertens. 9:1996;110-121.
4. Little WC, Cheng C-P, Elvelin L, Nordlander M. Vascular selective calcium entry blockers in the treatment of cardiovascular disorders. Focus on felodipine. Cardiovasc Drug Ther. 9:1995;657-663.
5. Pannarale G, Puddu PE, Monti F, Irace L, Bentivoglio M, Collauto F, Barsotti A, Corea L, Trevi G, Campa PP, Jacono A. Twenty-four-hour antihypertensive efficacy of felodipine 10 mg extended-release: the Italian inter-university study. J Cardiovasc Pharmacol. 27:1996;255-261.
6. Elvelin L, Jönsson L. The effect of dihydropyridine calcium antagonists on heart rate: studies of felodipine. Curr Ther Res. 55:1994;736-746.
7. The Australian therapeutic trial in mild hypertension. Lancet. i:1980;1261-1267.
8. MRC trial of treatment of mild hypertension: principal results. Br Med J. 291:1985;97-104.
9. Medical Research Council trial of treatment of hypertension in older adults: principal results. Br Med J. 304:1992;405-412.
10. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. JAMA. 265:1991;3255-3264.
11. Dahlöf B, Lindholm LH, Hansson L, Scherstén B, Ekbom T, Wester P-O. Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension). Lancet. 338:1991;1281-1285.
12. Grimm RH Jr, Whelton DP, Pressel S. The antihypertensive and lipid lowering treatment to prevent heart attack trial (ALLHAT): update on recruitment and baseline characteristics. Am J Hypertens. 9:1996;26A.
13. Dahlöf B, Hansson L, Lindholm LH, Scherstén B, Wester P-O, Ekbom T, Hedner T, De Faire U. STOP-Hypertension 2: a prospective intervention trial of "newer" versus "older" treatment alternatives in old patients with hypertension. Blood Press. 2:1993;136-141.
14. Hansson L. The Hypertension Optimal Treatment Study (The HOT study). Blood Press. 2:1993;62-68.
15. Hansson L, Zanchetti A. The Hypertension Optimal Treatment (HOT) Study: 12-month data on blood pressure and tolerability. With special reference to age and gender. Blood Press. 4:1995;313-319.